Hilal Celikkaya
Hilal Celikkaya
Unknown affiliation
Verified email at tu-dresden.de
Cited by
Cited by
3D Culture Method for Alzheimer's Disease Modeling Reveals Interleukin-4 Rescues Aβ42-Induced Loss of Human Neural Stem Cell Plasticity
C Papadimitriou, H Celikkaya, MI Cosacak, V Mashkaryan, L Bray, ...
Developmental cell 46 (1), 85-101. e8, 2018
Regulation of human dihydrofolate reductase activity and expression
EE Abali, NE Skacel, H Celikkaya, YC Hsieh
Vitamins & Hormones 79, 267-292, 2008
Stromal-based signatures for the classification of gastric cancer
MT Uhlik, J Liu, BL Falcon, S Iyer, J Stewart, H Celikkaya, M O'Mahony, ...
Cancer research 76 (9), 2573-2586, 2016
GATA3 promotes the neural progenitor state but not neurogenesis in primary human cortical astrocytes in 3D traumatic injury model
H Celikkaya, MI Cosacak, P Bhattarai, S Popova, C Papadimitriou, ...
Frontiers in Cellular Neuroscience 13, 23, 2019
mTOR inhibition leads to increased sensitivity to methotrexate
G Saydam, H Celikkaya, P Cole, JR Bertino, EA Ercikan-Abali
Cancer Research 65 (9 Supplement), 777-778, 2005
Immunization with UV-induced apoptotic cells generates monoclonal antibodies against proteins differentially expressed in hepatocellular carcinoma cell lines
H Celikkaya, C Ciraci, E Oztas, ME Avci, M Ozturk, T Yagci
Hybridoma 26 (2), 55-61, 2007
Interleukin-4 restores neurogenic plasticity of the primary human neural stem cells through suppression of Kynurenic acid production upon Amyloid-beta42 toxicity
C Papadimitriou, H Celikkaya, MI Cosacak, V Mashkaryan, P Bhattarai, ...
bioRxiv, 227306, 2017
Instructive starPEG-Heparin biohybrid 3D cultures for modeling human neural stem cell plasticity, neurogenesis, and neurodegeneration
C Papadimitriou, MI Cosacak, V Mashkaryan, H Celikkaya, L Bray, ...
bioRxiv, 225243, 2017
Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression
E Ercikan Abali, H Celikkaya, YC Hsieh, D Banerjee, J R Bertino
Current enzyme inhibition 8 (2), 107-117, 2012
Modulation of dihydrofolate reductase expression using NAD analogues
B Lawal, H Celikkaya, T Litvin-Vechnyak, J Bertino, EE Abali
Cancer Research 67 (9 Supplement), 3192-3192, 2007
Modulation of antifolate sensitivity in cancer chemotherapy using mTOR inhibitors
H Celikkaya, P Cole, J Bertino, EE Abali
Cancer Research 67 (9 Supplement), 4763-4763, 2007
Novel antifolates that do not upregulate thymidylate synthase and dihydrofolate reductase levels
H Celikkaya, HD Jain, Y Zeng, J Yang, X Lin, A Gangjee, JR Bertino, ...
Cancer Research 66 (8 Supplement), 131-131, 2006
Modulation of Antifolate Sensitivity in Cancer Chemotherapy
H Celikkaya
Celikkaya, 2007
The system can't perform the operation now. Try again later.
Articles 1–13